Boston Research & Management’s Albemarle Corp Depositary Shares ALB.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Sell
99,820
-1,000
-1% -$70.6K 1.22% 35
2026
Q1
$7.24M Sell
100,820
-3,200
-3% -$221K 1.69% 19
2025
Q4
$6.18M Sell
104,020
-4,400
-4% -$218K 1.4% 27
2025
Q3
$4.11M Sell
108,420
-13,540
-11% -$505K 0.9% 48
2025
Q2
$3.91M Buy
+121,960
New +$3.73M 0.92% 49

Other funds holding ALB.PRA

Boston Research & Management's ALB.PRA Position: Q2 2026 in Review

Boston Research & Management reduced its Albemarle Corp Depositary Shares (ALB.PRA) stake by 0.99% in Q2 2026, selling an estimated $70.6K and leaving 99,820 shares worth $5.53M. The position accounts for 1.22% of the portfolio, ranked #35.

Boston Research & Management first reported a position in ALB.PRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.24M in Q1 2026. 85 funds tracked by Wall St. Rank hold ALB.PRA as of Q2 2026.

  • Boston Research & Management held 99,820 shares of Albemarle Corp Depositary Shares worth $5.53M as of Q2 2026.
  • Boston Research & Management sold 1,000 Albemarle Corp Depositary Shares shares in Q2 2026, an estimated $70.6K.
  • Albemarle Corp Depositary Shares made up 1.22% of Boston Research & Management's portfolio in Q2 2026, its #35 holding.
  • Boston Research & Management first reported a position in Albemarle Corp Depositary Shares in Q2 2025 and has held it in 5 quarters since.
  • Boston Research & Management's Albemarle Corp Depositary Shares position peaked at $7.24M in Q1 2026.
  • 85 funds tracked by Wall St. Rank held Albemarle Corp Depositary Shares as of Q2 2026.

Based on Boston Research & Management's 13F filing for Q2 2026, filed 11 Aug 2026.